INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2011

The Endocrine Society guideline recommends vitamin D supplementation and serum 25(OH)D testing for at-risk patients, but not routine screening for others.

An Endocrine Society Task Force developed clinical practice guidelines for evaluating, treating, and preventing vitamin D deficiency based on systematic reviews of evidence. The Task Force recommended vitamin D supplementation at suggested daily intake and tolerable upper limit levels depending on age and clinical circumstances, and treatment with vitamin D2 or vitamin D3 for deficient patients. Serum 25-hydroxyvitamin D measurement was recommended for patients at risk for deficiency. Currently, there is insufficient evidence to recommend screening individuals not at risk or prescribing vitamin D for cardiovascular protection.

Study type
Clinical practice guideline
Who was studied
Patients at risk for vitamin D deficiency and individuals across all age groups
What was measured
Evaluation, treatment, and prevention of vitamin D deficiency

THE PAPER

Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline.

Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM, Endocrine Society. J Clin Endocrinol Metab, 2011.

PubMed 21646368 ↗DOI 10.1210/jc.2011-0385 ↗

Nutrients & adequacyBones & musclesOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.